A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)

Phase 4

Completed

Brief Summary: The goal of this study is to evaluate the impact of a chronic care model (CCM) based quality improvement program on 1) outcomes for patients with chronic kidney disease (CKD) and 2) adherence to CKD guidelines. This pilot study will evaluate the feasibility of a CCM based quality improvement program for patients with CKD and assess potential mechanisms for the intervention's effect.

Hypothesis: Implementing a CCM based quality improvement program including system level support in the form of collaborative care, a CKD registry, and provider education will 1) reduce systolic BP in patients with poorly controlled hypertension, 2) increase the percentage of patients appropriately monitored for metabolic complications, and 3) decrease the rate of catheter use in patients initiating dialysis.

Detailed Description: Research Plan:

The experimental design is a prospective, randomized controlled trial evaluating the impact of a Chronic Care Model (CCM) based quality improvement program on CKD guideline adherence. The intervention will focus on three main goals: 1) reduction of BP to target levels, 2) appropriate monitoring of patients for metabolic complications of CKD, and 3) reduced use of dialysis catheters in patients initiating dialysis. The CKD CCM QI program will include a lecture on CKD guidelines and hypertension to all CBOC providers and a centrally located pharmacist with access to the CKD registry.

Methodology:

Veterans receive primary care at Community Based Outpatient Centers (CBOCs) throughout Northeast Ohio. Patients with CKD who receive their primary care at a Northeast Ohio CBOC will be eligible for the study. The hypothesis was formulated before data collection.

Recruitment & Eligibility

Inclusion Criteria

receipt of primary care at a VISN 10 Northeast Ohio CBOC
GFR (calculated according to the 4 variable Modification of Diet in Renal Disease study equation) less than 45 mL/min per 1.73m2 with a second GFR less than 60 at least 90 to 730 days prior to the index GFR (26); and
at least one primary care visit in the year prior to study initiation.

Exclusion Criteria

ESRD as defined by chronic renal replacement therapy,
receipt of a renal transplant,
hospice care, and
age greater than 85 years or less than 18 years at the time of study initiation.

Arm && Interventions

Group	Intervention	Description
Pharmacist intervention	Pharmacist based QI program	-
Control - usual care	Usual Care	Patients assigned to control will continue to receive care from their VA provider.

Primary Outcome Measures

Name	Time	Method
Systolic Blood Pressure (SBP)	one year	Average SBP for those with a baseline BP \> 130/80

Secondary Outcome Measures

Name	Time	Method
Number of Participants With PTH Measurement During the Study Period	one year	The primary process outcome was measurement of PTH during the study period.